查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
動靜脈瘻管 (AVF) 設備市場規模、佔有率、趨勢分析報告：按類型、最終用途、按地區、細分市場預測，2023-2030年
市場調查報告書
商品編碼
1321412

動靜脈瘻管 (AVF) 設備市場規模、佔有率、趨勢分析報告：按類型、最終用途、按地區、細分市場預測，2023-2030年

Arteriovenous Fistula Devices Market Size, Share & Trends Analysis Report By Type (AVF Creation Devices, AVF Monitoring Devices, AVF Maintenance Devices), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

動靜脈內瘻管 (AVF) 器材市場成長與趨勢

Grand View Research 的最新報告顯示，到2030年，全球動靜脈內瘺 (AVF) 設備市場預計將達到 5.566 億美元。

預計2023年至2030年該市場將以7.6%的年複合成長率成長。 AVF 是動脈和靜脈之間的異常連接，可能由先天要素、創傷或外科手術引起。這些異常連接經常在四肢和內臟器官（包括肝臟和大腦）中觀察到。在醫學上，AVF 是專門為需要血液透析的末期腎臟病 (ESRD) 患者創建的。透過創建 AVF，醫療保健提供者可以建立可靠且永久的血流接入點，以進行有效的透析治療。

AVF 設備市場受到多種要素的推動，包括需要血液透析的 ESRD 盛行率不斷上升，而 AVF 的創建是為了為透析治療提供可靠的血管通路。此外，血管內治療和栓塞等微創手術的進步推動對 AVF 設備的需求。

主要參與者積極實施收購、合併、聯盟和強大的研發活動等策略性舉措，以增強其在市場上的主導地位。這些措施目的是加強產品系列、擴大我們的市場佔有率並推動 AVF 設備技術的創新。

例如，VentureMed Group 於2022年 5月完成了一項名為「PTA 前的 Flex Vessel Prep 用於治療天然 AVF 阻塞性病變」的隨機對照試驗 (RCT) 的入組。此臨床試驗評估了在經皮成形術 (PTA) 之前使用 Flex 血管準備系統治療上肢 AVF 的閉塞性病變，初步設計用於評估通暢性。此類研究措施在產生臨床證據和證明 AVF 裝置的有效性和安全性方面發揮重要作用。

因此，隨著公司投資研發，可以期待創新設備的推出，以提高 AVF 的通暢性，最大限度地減少併發症，並為 AVF 患者提供卓越的解決方案。

AVF 設備市場報告亮點

  • 2022年，製造部門佔營收佔有率最大，為46.97%。製造的節段在使 AVF 手術有效和成功、實現最佳透析治療和改善患者預後方面發揮關鍵作用。創新的製造技術和技術進步提高成功率、減少併發症並改善患者照護，進一步推動該領域的成長。
  • 2022年，醫院板塊收入佔比最大，為54.20%。這項優勢歸功於先進的基礎設施、熟練的醫療專業人員以及償付系統要素，這些因素進一步促進了 AVF 設備在醫院的使用。
  • 2022年，北美地區佔據了壓倒性的收入佔有率，達到47.59%。這一巨大的市場佔有率主要是由於該地區 ESRD 的患病率不斷上升、對透析治療的需求不斷增加以及對有效 AVF 設備的需求。
  • 主要市場參與者包括 Medtronic、BD、Teleflex Incorporated、Fresenius Medical Care AG &Co.KGaA.、B. Braun SE、Polymedicure、NxStage Medical, Inc. 和 Laminate Medical Technologies。

目錄

第1章 調查方法和範圍

  • 市場區隔和範圍
  • 區域範圍
  • 估計/預測時間表
  • 調查方法
  • 資訊採購
  • 資訊分析
  • 市場形成和資料可視化
  • 型號詳情
  • 二手資訊清單

第2章 執行摘要

第3章 市場變數、趨勢和範圍

  • 市場體系預測
    • 母市場預測
    • 相關/附隨市場預測
  • 市場趨勢及展望
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 營商環境分析
    • PESTLE分析
    • 波特五力分析
  • COVID-19感染疾病的影響分析

第4章 業務分析的類型

  • AVF 設備市場：2022年和2030年類型變化分析
  • 製造
  • 監控
  • 維護

第5章 最終用途業務分析

  • AVF 設備市場：2022年和2030年最終用途變化分析
  • 醫院
  • 門診手術中心
  • 透析中心

第6章 區域業務分析

  • 區域市場簡介
  • 北美洲
    • 北美 AVF 設備市場
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲 AVF 設備市場
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區 AVF 設備市場
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 拉丁美洲 AVF 設備市場
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東、非洲
    • 中東、非洲 AVF 設備市場
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭形勢

  • 公司分類
  • 策略規劃
    • 獲得
    • 合作
    • 宣布新平台
    • 其他
  • 公司簡介/名單
    • BD
    • Medtronic
    • Teleflex Incorporated
    • Fresenius Medical Care AG &Co. KGaA
    • Polymedicure
    • NxStage Medical, Inc
    • Laminate Medical Technologies
    • B. Braun SE
Product Code: GVR-4-68040-099-5

AV Fistula Devices Market Growth & Trends

The global AV fistula devices market size is expected to reach USD 556.6 million by 2030, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 7.6% from 2023 to 2030. AVFs are abnormal connections between arteries and veins, which can arise from congenital factors, trauma, or surgical procedures. These abnormal connections are frequently observed in both limbs and internal organs, including the liver and brain. In the context of healthcare, AVFs are deliberately established for patients suffering from End-stage Renal Disease (ESRD) who necessitate hemodialysis. By creating AVFs, healthcare providers can establish a dependable and enduring access point to the bloodstream for efficient dialysis treatments.

The market for arteriovenous fistula (AVF) devices is driven by several factors, including the rising prevalence of ESRD necessitating hemodialysis, where AVFs are created to provide reliable vascular access for dialysis treatments. In addition, advancements in minimally invasive procedures, such as endovascular techniques and embolization, have fueled the demand for AVF devices.

Key players are actively implementing strategic initiatives, including acquisitions, mergers, collaborations, and robust research and development activities, to enhance their market dominance. These initiatives aim to strengthen their product portfolios, expand their market presence, and drive innovation in AVF device technologies.

For instance, in May 2022 VentureMed Group completed the enrollment of a Randomized Controlled Trial (RCT) named 'Flex Vessel Prep before PTA for the treatment of obstructive lesions in the native AVF.' This clinical trial was designed to evaluate the primary patency at six months by utilizing the Flex Vessel Prep system before Percutaneous Transluminal Angioplasty (PTA), compared to PTA alone, for treating obstructive lesions in native AVFs in the upper extremity. Such research initiatives play a crucial role in generating clinical evidence and demonstrating the efficacy and safety of AVF devices.

Thus, as companies invest in research and development, the market can expect the introduction of innovative devices that enhance AVF patency, minimize complications, and provide superior solutions for patients with AVFs.

AV Fistulas Devices Market Report Highlights

  • In 2022, the AVF creation devices segment held the largest revenue share of 46.97%. AVF creation devices play a crucial role in enabling effective and successful AVF procedures, allowing for optimal dialysis treatment and improving patient outcomes. The advancement of innovative AVF creation technologies and techniques further drives the growth of this segment, as they offer improved success rates, reduced complications, and enhanced patient care
  • In 2022, the hospital segment held the largest revenue share of 54.20%. This dominance can be attributed to the factors such as the availability of advanced infrastructure, skilled healthcare professionals, and access to reimbursement systems that further fuel the utilization of AVF devices in hospitals
  • In 2022, North America held the dominant revenue share of 47.59%. This significant market share is primarily attributed to the increasing prevalence of ESRD in the region has led to a higher demand for dialysis treatment, creating a need for effective AVF devices
  • Key market players include Medtronic; BD; Teleflex Incorporated; Fresenius Medical Care AG & Co. KGaA., B. Braun SE; Polymedicure; NxStage Medical, Inc.; and Laminate Medical Technologies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Market Definitions
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Trends and Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Business Environment Analysis
    • 3.4.1. PESTLE Analysis
    • 3.4.2. Porter's Five Forces Analysis
  • 3.5. COVID-19 Impact Analysis

Chapter 4. Type Business Analysis

  • 4.1. Arteriovenous Fistulas Device (AVF) Market: Type Movement Analysis, 2022 & 2030
  • 4.2. AVF Creation Devices
    • 4.2.1. AVF Creation Devices Market, 2018 - 2030 (USD Million)
      • 4.2.1.1. Surgical Instruments
      • 4.2.1.1.1. Surgical Instruments Market, 2018 - 2030 (USD Million)
      • 4.2.1.2. Vascular Grafts
      • 4.2.1.2.1. Vascular Grafts Market, 2018 - 2030 (USD Million)
      • 4.2.1.3. Angioplasty Balloons
      • 4.2.1.3.1. Angioplasty Balloons Market, 2018 - 2030 (USD Million)
      • 4.2.1.4. Others
      • 4.2.1.4.1. Others Market, 2018 - 2030 (USD Million)
  • 4.3. AVF Monitoring Devices
    • 4.3.1. AVF Monitoring Devices Market, 2018 - 2030 (USD Million)
      • 4.3.1.1. Doppler Ultrasound
      • 4.3.1.1.1. Doppler Ultrasound Market, 2018 - 2030 (USD Million)
      • 4.3.1.2. Pressure Monitoring Systems
      • 4.3.1.2.1. Pressure Monitoring Systems Market, 2018 - 2030 (USD Million)
      • 4.3.1.3. Others
      • 4.3.1.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.4. AVF Maintenance Devices
    • 4.4.1. AVF Maintenance Devices Market, 2018 - 2030 (USD Million)
      • 4.4.1.1. Central Venous Catheters
      • 4.4.1.1.1. Central Venous Catheters Market, 2018 - 2030 (USD Million)
      • 4.4.1.2. Stents
      • 4.4.1.2.1. Stents Market, 2018 - 2030 (USD Million)
      • 4.4.1.3. Others
      • 4.4.1.3.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. End-Use Business Analysis

  • 5.1. Arteriovenous Fistulas Device (AVF) Market: End-use Movement Analysis, 2022 & 2030
  • 5.2. Hospitals
    • 5.2.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 5.3. Ambulatory Surgical Centers
    • 5.3.1. Ambulatory Surgical Centers Market, 2018 - 2030 (USD Million)
  • 5.4. Dialysis Centers
    • 5.4.1. Dialysis Centers Market, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis

  • 6.1. Regional Market Snapshot
  • 6.2. North America
    • 6.2.1. North America Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.2.2.2. Key Country Dynamics
      • 6.2.2.3. Regulatory Framework
      • 6.2.2.4. Competitive Scenario
    • 6.2.3. Canada
      • 6.2.3.1. Canada Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.2.3.2. Key Country Dynamics
      • 6.2.3.3. Regulatory Framework
      • 6.2.3.4. Competitive Scenario
  • 6.3. Europe
    • 6.3.1. Europe Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.3.2. Germany
      • 6.3.2.1. Germany Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.2.2. Key Country Dynamics
      • 6.3.2.3. Regulatory Framework
      • 6.3.2.4. Competitive Scenario
    • 6.3.3. UK
      • 6.3.3.1. UK Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.3.2. Key Country Dynamics
      • 6.3.3.3. Regulatory Framework
      • 6.3.3.4. Competitive Scenario
    • 6.3.4. France
      • 6.3.4.1. France Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.4.2. Key Country Dynamics
      • 6.3.4.3. Regulatory Framework
      • 6.3.4.4. Competitive Scenario
    • 6.3.5. Italy
      • 6.3.5.1. Italy Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.5.2. Key Country Dynamics
      • 6.3.5.3. Regulatory Framework
      • 6.3.5.4. Competitive Scenario
    • 6.3.6. Spain
      • 6.3.6.1. Spain Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.6.2. Key Country Dynamics
      • 6.3.6.3. Regulatory Framework
      • 6.3.6.4. Competitive Scenario
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.7.2. Key Country Dynamics
      • 6.3.7.3. Regulatory Framework
      • 6.3.7.4. Competitive Scenario
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.8.2. Key Country Dynamics
      • 6.3.8.3. Regulatory Framework
      • 6.3.8.4. Competitive Scenario
    • 6.3.9. Norway
      • 6.3.9.1. Norway Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.3.9.2. Key Country Dynamics
      • 6.3.9.3. Regulatory Framework
      • 6.3.9.4. Competitive Scenario
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.2.2. Key Country Dynamics
      • 6.4.2.3. Regulatory Framework
      • 6.4.2.4. Competitive Scenario
    • 6.4.3. China
      • 6.4.3.1. China Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.3.2. Key Country Dynamics
      • 6.4.3.3. Regulatory Framework
      • 6.4.3.4. Competitive Scenario
    • 6.4.4. India
      • 6.4.4.1. India Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.4.2. Key Country Dynamics
      • 6.4.4.3. Regulatory Framework
      • 6.4.4.4. Competitive Scenario
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.5.2. Key Country Dynamics
      • 6.4.5.3. Regulatory Framework
      • 6.4.5.4. Competitive Scenario
    • 6.4.6. Australia
      • 6.4.6.1. Australia Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.6.2. Key Country Dynamics
      • 6.4.6.3. Regulatory Framework
      • 6.4.6.4. Competitive Scenario
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.4.7.2. Key Country Dynamics
      • 6.4.7.3. Regulatory Framework
      • 6.4.7.4. Competitive Scenario
  • 6.5. Latin America
    • 6.5.1. Latin America Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.2.2. Key Country Dynamics
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Competitive Scenario
    • 6.5.3. Mexico
      • 6.5.3.1. Mexico Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.3.2. Key Country Dynamics
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Competitive Scenario
    • 6.5.4. Argentina
      • 6.5.4.1. Argentina Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.5.4.2. Key Country Dynamics
      • 6.5.4.3. Regulatory Framework
      • 6.5.4.4. Competitive Scenario
  • 6.6. MEA
    • 6.6.1. MEA Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.2.2. Key Country Dynamics
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Competitive Scenario
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.3.2. Key Country Dynamics
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Competitive Scenario
    • 6.6.4. UAE
      • 6.6.4.1. UAE Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.4.2. Key Country Dynamics
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Competitive Scenario
    • 6.6.5. Kuwait
      • 6.6.5.1. UAE Arteriovenous Fistulas Device (AVF) Market, 2018 - 2030 (USD Million)
      • 6.6.5.2. Key Country Dynamics
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Competitive Scenario

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
    • 7.2.1. Acquisition
    • 7.2.2. Collaborations
    • 7.2.3. New Platform Launches
    • 7.2.4. Others
  • 7.3. Company Profiles/Listing
    • 7.3.1. BD
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Performance
      • 7.3.1.3. Platform Benchmarking
      • 7.3.1.4. Strategic Initiatives
    • 7.3.2. Medtronic
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Performance
      • 7.3.2.3. Platform Benchmarking
      • 7.3.2.4. Strategic Initiatives
    • 7.3.3. Teleflex Incorporated
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Performance
      • 7.3.3.3. Platform Benchmarking
      • 7.3.3.4. Strategic Initiatives
    • 7.3.4. Fresenius Medical Care AG & Co. KGaA
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Financial Performance
      • 7.3.4.3. Platform Benchmarking
      • 7.3.4.4. Strategic Initiatives
    • 7.3.5. Polymedicure
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Performance
      • 7.3.5.3. Platform Benchmarking
      • 7.3.5.4. Strategic Initiatives
    • 7.3.6. NxStage Medical, Inc
      • 7.3.6.1. Company Overview
      • 7.3.6.2. Financial Performance
      • 7.3.6.3. Platform Benchmarking
      • 7.3.6.4. Strategic Initiatives
    • 7.3.7. Laminate Medical Technologies
      • 7.3.7.1. Company Overview
      • 7.3.7.2. Financial Performance
      • 7.3.7.3. Platform Benchmarking
      • 7.3.7.4. Strategic Initiatives
    • 7.3.8. B. Braun SE
      • 7.3.8.1. Company Overview
      • 7.3.8.2. Financial Performance
      • 7.3.8.3. Platform Benchmarking
      • 7.3.8.4. Strategic Initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 Global Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 3 Global Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 4 Global Arteriovenous Fistulas (AVF) devices market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 8 U.S. Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 Canada Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 14 Europe Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Germany Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 16 Germany Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 17 UK Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 18 UK Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 France Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 20 France Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 21 Italy Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 22 Italy Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Spain Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 24 Spain Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Denmark Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 26 Denmark Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 27 Sweden Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 28 Sweden Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 Norway Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 30 Norway Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 33 China Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 34 China Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Japan Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 36 Japan Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 India Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 38 India Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 39 South Korea Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 40 South Korea Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Australia Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 42 Australia Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Thailand Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 44 Thailand Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 45 Latin America Arteriovenous Fistulas (AVF) devices market, by country, 2018 - 2030 (USD Million)
  • Table 46 Latin America Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 47 Latin America Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 48 Brazil Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 49 Brazil Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 Mexico Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 51 Mexico Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 52 Argentina Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 53 Argentina Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Africa Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 57 South Africa Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 UAE Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 61 UAE Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait Arteriovenous Fistulas (AVF) devices market, by type, 2018 - 2030 (USD Million)
  • Table 63 Kuwait Arteriovenous Fistulas (AVF) devices market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Arteriovenous fistulas (AVF) devices market segmentation
  • Fig. 7 Market snapshot, 2022
  • Fig. 8 Market trends & outlook
  • Fig. 9 Market driver relevance analysis (current & future impact)
  • Fig. 10 Market restraint relevance analysis (current & future impact)
  • Fig. 11 Swot analysis, by factor (political & legal, economic and technological)
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 Global Arteriovenous Fistulas (AVF) devices market: Type Outlook Key Takeaways
  • Fig. 14 Global Arteriovenous Fistulas (AVF) devices market: Type Movement Analysis
  • Fig. 15 Global AVF creation devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 16 Global AVF monitoring devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 17 Global AVF maintenance devices Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 18 Global Arteriovenous Fistulas (AVF) devices market: End-use Outlook Key Takeaways
  • Fig. 19 Global Arteriovenous Fistulas (AVF) devices market: End-use Movement Analysis
  • Fig. 20 Global hospital market, 2018 - 2030 (USD Million)
  • Fig. 21 Global ambulatory surgical centers market, 2018 - 2030 (USD Million)
  • Fig. 22 Global dialysis centers market, 2018 - 2030 (USD Million)
  • Fig. 23 Regional Marketplace: Key Takeaways
  • Fig. 24 Regional outlook, 2022 & 2030
  • Fig. 25 Global Arteriovenous Fistulas (AVF) devices market: Regional Movement Analysis
  • Fig. 26 North America Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 27 U.S. Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 28 Canada Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 29 Europe Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 30 Germany Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 31 UK Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 32 France Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 33 Italy Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 34 Spain Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Denmark Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Sweden Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 37 Norway Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Asia Pacific Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 39 Japan Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 40 China Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 41 India Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Australia Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 43 South Korea Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 44 Thailand Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 45 Latin America Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 46 Brazil Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Mexico Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Argentina Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Middle East and Africa Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 50 South Africa Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 51 Saudi Arabia Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 52 UAE Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Kuwait Arteriovenous Fistulas (AVF) devices market, 2018 - 2030 (USD Million)